Nakamoto, Inc. (NAKA)
5.00
-0.79
(-13.64%)
USD |
NASDAQ |
Nov 13, 16:00
4.93
-0.07
(-1.40%)
After-Hours: 19:59
Nakamoto Total Liabilities (Quarterly) : 192.92M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 192.92M |
| June 30, 2026 | 186.10M |
| March 31, 2026 | 253.69M |
| December 31, 2025 | 216.35M |
| September 30, 2025 | 214.86M |
| June 30, 2025 | 0.9234M |
| March 31, 2025 | 1.034M |
| December 31, 2024 | 1.110M |
| Date | Value |
|---|---|
| September 30, 2024 | 0.8401M |
| June 30, 2024 | 1.076M |
| March 31, 2024 | 1.182M |
| December 31, 2023 | 1.208M |
| September 30, 2023 | 1.049M |
| June 30, 2023 | 0.8784M |
| March 31, 2023 | 0.8064M |
| December 31, 2022 | 0.566M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Astrana Health, Inc. | 1.712B |
| Agilon Health, Inc. | 1.285B |
| Starling Oncology, Inc. | 225.13M |
| American Oncology Network, Inc. | -- |
| Biodesix, Inc. | 85.27M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 517.19M |
| Shareholders Equity (Quarterly) | 324.28M |
| Debt to Equity Ratio | 0.5084 |
| Current Ratio | 0.2278 |
| Net Debt Paydown Yield | -18.93% |